Cite
Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer
MLA
Leonardo Bugatti, et al. “Diffuse Scleroderma Occurring after the Use of Paclitaxel for Ovarian Cancer.” Clinical Rheumatology, vol. 22, Feb. 2003, pp. 49–52. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2f43f3cedc17b1b778455d67ed0dceee&authtype=sso&custid=ns315887.
APA
Leonardo Bugatti, Giorgio Filosa, R. De Angelis, P Del Medico, & A Cerioni. (2003). Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer. Clinical Rheumatology, 22, 49–52.
Chicago
Leonardo Bugatti, Giorgio Filosa, R. De Angelis, P Del Medico, and A Cerioni. 2003. “Diffuse Scleroderma Occurring after the Use of Paclitaxel for Ovarian Cancer.” Clinical Rheumatology 22 (February): 49–52. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2f43f3cedc17b1b778455d67ed0dceee&authtype=sso&custid=ns315887.